| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 8.834 | 6.080 | 839 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | 0 | 10.591 | 9.188 | 3.836 | 614 | 0 | 0 |
| Total Expenses - EUR | - | - | - | 2.949 | 9.108 | 2.739 | 5.142 | 643 | 0 | 0 |
| Gross Profit/Loss - EUR | - | - | - | -2.949 | 1.483 | 6.449 | -1.307 | -29 | 0 | 0 |
| Net Profit/Loss - EUR | - | - | - | -2.949 | 1.165 | 6.205 | -1.393 | -47 | 0 | 0 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Aurelian Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 90 | 49.787 | 46.830 | 42.861 | 42.380 | 42.252 | 42.016 |
| Current Assets | - | - | - | 1.409 | 2.590 | 105.872 | 3.419 | 0 | 0 | 0 |
| Inventories | - | - | - | 0 | 885 | 868 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 645 | 0 | 98.324 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | 765 | 1.705 | 6.680 | 3.419 | 0 | 0 | 0 |
| Shareholders Funds | - | - | - | -2.906 | -1.684 | 4.553 | 3.058 | 0 | 0 | 0 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 4.405 | 4.274 | 5.400 | 361 | 0 | 0 | 0 |
| Income in Advance | - | - | - | 0 | 49.787 | 142.749 | 42.861 | 42.380 | 42.252 | 42.016 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5520 - 5520" | |||||||||
| CAEN Financial Year |
5520
|
|||||||||
Comments - Aurelian Med S.r.l.